At a glance
- ACIP Committee members and representatives serve on the Committee voluntarily.
Helen K. Talbot, MD, MPH
Professor of Medicine and Health Policy, Division of Infectious Diseases, Vanderbilt University, Nashville, Tennessee. Term: 10/29/2018 – 6/30/2023
As a dual appointee in Medicine and Health Policy, Dr. Talbot has played a pivotal role in the evaluation of viral respiratory diseases in adults and the evaluation of new and existing vaccines in older adults so as to improve immunization policy and vaccine development. Her goal is to continue to evaluate the use and effectiveness of vaccines, with a focus on prevention of infection and morbidity in adults. Dr. Talbot began her career by investigating the presentation of influenza in hospitalized adults. Her recent work has contributed to our understanding of the epidemiology of SARS-CoV-2, influenza, and respiratory syncytial virus. Dr. Talbot currently co-leads the Tennessee Emerging Infections Program at Vanderbilt, which works to better understand viral respiratory disease epidemiology and inform vaccine policy.
Edwin Jose Asturias, MD
Professor of Pediatrics and Infectious Diseases Epidemiology, University of Colorado School of Medicine and Colorado School of Public Health, Aurora, CO. Term: 7/1/2024 – 6/30/2028
Dr. Edwin Asturias is a tenured professor of pediatric infectious disease and epidemiology at the University of Colorado with expertise in global health and infectious diseases. Dr. Asturias has had a notable track record in advancing research on vaccine-preventable diseases and improving healthcare delivery in underserved regions. His work has focused on vaccine introduction strategies and vaccine safety. He has served in several national and international committees including the World Health Organization Global Advisory Committee on Vaccine Safety. His research has advanced policies on vaccines to eradicate poliomyelitis and introduce vaccines for indigenous communities in the Americas.
Noel T. Brewer, MS, PhD
Gillings Distinguished Professor in Public Health, Gillings School of Global Public Health, Chapel Hill, NC. Term: 7/1/2024 – 6/30/2028
Dr. Brewer is a behavioral scientist who studies vaccination, tobacco cessation, and other health behaviors. His research examines why people get vaccinated, improving patient communication, and other interventions to improve coverage. Dr. Brewer has advised on HPV vaccination for the President's Cancer Panel under Presidents Obama and Trump and to the Biden Cancer initiative. He has advised CDC, WHO and other organizations on assessing the behavioral and social drivers of vaccine uptake. Dr. Brewer developed the Announcement Approach Training to make HPV vaccination communication more effective, which has been recognized by the National Cancer Institute and is used nationally.
Oliver Brooks, MD, FAAP
Oliver Brooks, MD, FAAP, Chief Medical Officer, Watts HealthCare Corporation, Los Angeles, CA. Term: 7/26/2021 – 6/30/2025
Dr. Brooks is Chief Medical Officer at Watts Healthcare Corporation in Los Angeles, California. He is a past president of the National Medical Association (NMA), and past president of the California Immunization Coalition. He was co-chair of the California COVID-19 Vaccine Work Group, which determined allocation of the COVID-19 vaccine in the state, and had worked for more than 15 years in various leadership roles focusing on disparities in vaccine coverage rates.
Lin H. Chen, MD, FACP, FASTMH, FISTM
Director, Mount Auburn Travel Medicine Center, Cambridge, MA. Term: 7/1/2024 – 6/30/2028
Dr. Chen is Associate Professor of Medicine at Harvard Medical School and Director of the Travel Medicine Center at Mount Auburn Hospital in Cambridge, Massachusetts, in Beth Israel Lahey Health. She is a Past President of the International Society of Travel Medicine, an organization with worldwide experts on vaccines. She has collaborated closely with the American Society of Tropical Medicine and Hygiene and other organizations on scientific and educational programs, including many vaccination topics. She has served on past ACIP work groups and is section editor/author of the CDC Health Information for International Travel.
Helen Y. Chu, MD, MPH, FIDSA
Professor of Medicine, University of Washington School of Medicine, Seattle, WA. Term: 7/1/2024 – 6/30/2028
Dr. Chu is a board-certified infectious disease physician and Professor of Medicine and Epidemiology at the University of Washington. She studies respiratory viruses and vaccines, and has conducted large-scale community surveillance studies and clinical trials of influenza, SARS-CoV-2, and respiratory syncytial virus vaccines and therapeutics in both domestic and international settings. She is a member of multiple NIH, CDC, and international expert working groups on respiratory viruses and vaccines.
Sybil Cineas, MD, FAAP, FACP
Sybil Cineas, MD, FAAP, FACP, Associate Professor of Medicine, Pediatrics, and Medical Science (Clinical), The Warren Alpert Medical School of Brown University, Associate Program Director, Brown Combined Residency in Internal Medicine and Pediatrics, Providence, RI. Term: 7/28/2021 – 6/30/2025
Dr. Cineas is dual board certified in Internal Medicine and Pediatrics and serves as the Associate Program Director for the Brown Combined Internal Medicine-Pediatrics Residency Program. In addition to servings as a primary care provider for patients of all ages, she is highly involved in the training of residents and medical students. She has 20+ years of experience teaching about and promoting vaccination in the clinical setting.
Denise J. Jamieson, MD, MPH
Vice President for Medical Affairs, Dean, Carver College of Medicine, University of Iowa. Term: 3/4/2024 – 6/30/2027
Dr. Jamieson is the Vice President for Medical Affairs, Dean of the Carver College of Medicine, and Professor of Obstetrics and Gynecology at the University of Iowa. Her scientific work has focused on emerging infections and vaccines in pregnancy. She retired from the U.S. Public Health Service in 2017 after 20 years of service at the Centers for Disease Control and Prevention (CDC). She is a member of the National Academy of Medicine.
Mini Kamboj, MD, FIDSA, FSHEA
Attending Physician, Memorial Sloan Kettering Cancer Center, New York, NY. Term: 7/1/2024 – 6/30/2028
Dr. Kamboj is a board-certified infectious disease physician and Professor of Medicine at Weill Cornell Medical College, Cornell University. She is also the Chief Medical epidemiologist at Memorial Sloan Kettering Cancer Center in New York City. Her research interests and clinical practice focus on improving immunization approaches for people undergoing treatment for cancer, hematopoietic stem cell transplant, and other immunocompromising conditions. She has served as the co-chair of the American Society of Clinical Oncology (ASCO) vaccine guideline panel and the American Society for Transplantation and Cellular Therapy (ASTCT) guideline member for COVID-19 and other vaccine-preventable illnesses.
George Kuchel, MD CM, FRCP, AGSF, FGSA, FAAAS
Professor and Travelers Chair, Geriatrics and Gerontology, UConn Center on Aging, Farmington, CT. Term: 7/1/2024 – 6/30/2028
Dr. Kuchel is a Geriatrician, Professor of Medicine, Travelers Chair in Geriatrics and Gerontology, and Director of the UConn Center on Aging at UConn Health in Farmington, CT. His work focuses on Precision Gerontology and Geroscience. This effort seeks to enhance function and independence in older adults in part by targeting the heterogeneity of altered immune responses to influenza, pneumococcal and SARS-CoV-2 vaccines with aging. Dr Kuchel leads the UConn NIA-funded Claude D Pepper Older Americans Independence Center, the NIA Geroscience Education and Training Network, and the KAPP-Sen NIH Cellular Senescence Tissue Mapping Center, while also serving as MPI of the NIA Translational Geroscience Network.
Jamie Loehr, MD, FAAFP
Jamie Loehr, MD, FAAFP, Owner, Cayuga Family Medicine, Ithaca, NY. Term: 7/26/2021 – 6/30/2025
Dr. Loehr has practiced as a family physician in Rochester and Ithaca, NY, for over 30 years, counseling patients every day on the benefits of vaccines. He served as the AAFP liaison to the ACIP for four years and has been a member of the ACIP influenza working group for over 10 years.
Yvonne (Bonnie) Maldonado, MD
Senior Associate Dean for Faculty Development and Diversity, Lucile Packard Children's Hospital at Stanford, Department of Pediatrics, Palo Alto, CA
Dr. Maldonado is a pediatric infectious diseases clinician, researcher and epidemiologist. She has led several NIH, CDC, Gates Foundation and WHO funded pediatric vaccine effectiveness studies in the US, India, Mexico and Sub-Saharan Africa, as well as studies of the prevention and treatment of perinatal HIV infection. She has served on several national and international committees in the area of pediatrics, vaccines and infectious diseases, including as former chair of the Committee on Infectious Diseases of the American Academy of Pediatrics. Dr. Maldonado has also devoted substantial effort to teaching, training, and mentoring activities in Global Child Health, Infectious Diseases and Epidemiology in the national and international setting.
Charlotte A. Moser, MS
Co-Director, Vaccine Education Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Term: 7/1/2024 – 6/30/2028
Ms. Moser has extensively published in scientific journals on the topics of immunology and virology. Through her research, Ms. Moser has contributed to our understanding of how vaccines prevent infections of the intestinal tract. She has also developed a novel method to enhance immune responses to vaccines. As co-director of the Vaccine Education Center, Ms. Moser has developed a variety of educational materials about vaccines, created the Parents PACK program for parents, and co-created the Vaccine Update and Vax Pack Hero programs.
Robert Schechter, MD, MSc
Chief, Immunization Branch, California Department of Public Health, Richmond, CA.
Dr. Schechter is Chief of the California Department of Public Health Immunization Branch, where he has worked for over 20 years. He has served on the National Vaccine Advisory Committee and on ACIP workgroups reviewing COVID-19, influenza, and other vaccines.
Albert C. Shaw, MD, PhD, FIDSA
Professor of Medicine, Yale School of Medicine,New Haven, Connecticut. Term: 3/4/2024 – 6/30/2027
Dr. Shaw is Professor of Medicine in the Section of Infectious Diseases at the Yale School of Medicine. He is an infectious diseases physician who is also an expert on changes in immune system function in older adults. His laboratory research seeks to understanding mechanisms underlying age-related chronic inflammation, circadian regulation of the immune response, and altered responses to vaccination.